TY - JOUR
T1 - The step-and-shoot IMRT overshooting phenomenon
T2 - a novel method to mitigate patient overdosage
AU - Zhen, Heming
AU - Ouyang, Luo
AU - Bao, Qinan
AU - Qin, Nan
AU - Stojadinovic, Strahinja
AU - Pompos, Arnold
N1 - Publisher Copyright:
© 2016 The Authors.
Copyright:
Copyright 2017 Medline is the source for the citation and abstract of this record.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - The goal of this work is to evaluate the dosimetric impact of an overshooting phenomenon in step-and-shoot IMRT delivery, and to demonstrate a novel method to mitigate the issue. Five pelvis IMRT patients treated on Varian 2100C EX linacs with larger than +4.5% phantom ion chamber point-dose difference relative to planned dose were investigated. For each patient plan, 5 fractions were delivered. DynaLog files were recorded and centi-MU pulses from dose integrator board for every control point (CP) were counted using a commercial pulse counter. The counter recorded CP MU agrees with DynaLog records, both showing an ~0.6 MU overshoot of the first segment of every beam. The 3D patient dose was recalculated from the counter records and compared to the planned dose, showing that the overshoot resulted in on average 2.05% of PTV D95 error, and 2.49%, 2.61% and 2.45% of D1cc error for rectum, bladder, and bowel, respectively. The initial plans were then modified by inserting a specially designed MLC segment to the start of every beam. The modified plans were also delivered five times. The dose from the modified delivery was calculated using counter recorded CP MU. The corresponding Dx parameters were all within 0.31% from the original plan. IMRT QA results also show a 2.2% improvement in ion chamber point-dose agreement. The results demonstrate that the proposed plan modification method effectively eliminates the overdosage from the overshooting phenomenon. PACS number(s): 87.55.Qr, 87.55.km.
AB - The goal of this work is to evaluate the dosimetric impact of an overshooting phenomenon in step-and-shoot IMRT delivery, and to demonstrate a novel method to mitigate the issue. Five pelvis IMRT patients treated on Varian 2100C EX linacs with larger than +4.5% phantom ion chamber point-dose difference relative to planned dose were investigated. For each patient plan, 5 fractions were delivered. DynaLog files were recorded and centi-MU pulses from dose integrator board for every control point (CP) were counted using a commercial pulse counter. The counter recorded CP MU agrees with DynaLog records, both showing an ~0.6 MU overshoot of the first segment of every beam. The 3D patient dose was recalculated from the counter records and compared to the planned dose, showing that the overshoot resulted in on average 2.05% of PTV D95 error, and 2.49%, 2.61% and 2.45% of D1cc error for rectum, bladder, and bowel, respectively. The initial plans were then modified by inserting a specially designed MLC segment to the start of every beam. The modified plans were also delivered five times. The dose from the modified delivery was calculated using counter recorded CP MU. The corresponding Dx parameters were all within 0.31% from the original plan. IMRT QA results also show a 2.2% improvement in ion chamber point-dose agreement. The results demonstrate that the proposed plan modification method effectively eliminates the overdosage from the overshooting phenomenon. PACS number(s): 87.55.Qr, 87.55.km.
KW - IMRT overshoot
UR - http://www.scopus.com/inward/record.url?scp=85047289892&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047289892&partnerID=8YFLogxK
U2 - 10.1120/jacmp.v17i4.6101
DO - 10.1120/jacmp.v17i4.6101
M3 - Article
C2 - 27455482
AN - SCOPUS:85047289892
VL - 17
SP - 214
EP - 222
JO - Journal of Applied Clinical Medical Physics
JF - Journal of Applied Clinical Medical Physics
SN - 1526-9914
IS - 4
ER -